$12.5B revenue (2025), Jersey City) spun from Johnson & Johnson in 2023 and operates consumer health brands including Listerine, Flonase, and Optrex across oral care, respiratory health, and wound care. Kimberly-Clark acquisition announced in 2026 consolidates two major consumer health portfolios.
Full PSI intelligence, network analysis, EDGAR filings, and predicted links require an access token.
Notes, edit suggestions, or content requests - sent directly to James.